Iron serves vital functions in the economy of the body in a variety of ways. Its role as an integral part of biologically important substances is well known. In heme, it forms a part of the oxygen-carrying compounds, hemoglobin and myoglobin, and of the cytochromes, cytochrome oxidase, catalase and perioxidase. Another enzyme, succinic dehydrogenase, appears to contain iron (1), but not bound as heme. Physiologic vasodepressor activity has also been ascribed to the iron storage compound, ferritin (2) . Less well known, perhaps, is the relatively recently described function of iron as a cofactor in several important enzymatic reactions (3) (4) (5) . Knowledge of this function of iron served as the basis for the current investigation.
In previous studies of the pathologic physiology of the iron-deficiency state, we have examined the fate of the heme compounds: hemoglobin, cytochrome c (6, 7) , catalase (7, 8) , cytochrome oxidase (9) , and succinic dehydrogenase (10) . Contrary to the earlier conclusions of Hahn and Whipple (11) , but in agreement with those of Gubler, Cartwright and Wintrobe (12), we found that varying degrees of depletion in several iron enzymes occurred in the iron-deficiency state. In the current study, we have undertaken measurement of aconitase. an enzyme that is not known to contain iron, but that appears to require iron as a specific cofactor (5) . Dialyzed solutions of aconitase lose their activity. Dickman and Cloutier (5) demonstrated that the addition of iron and a reducing agent reactivated the enzyme.
None of the many other ions tested had the capacity to reactivate aconitase (5, 13) .
Aconitase catalyzes the biologically important equilibrium between citrate, isocitrate and cisaconitase. Takeda and Hara (14) have reported that activity of aconitase is diminished in livers of guinea pigs poisoned with a-a'-dipyridyl, and that marked citric acid diuresis occurred in these animals, especially after loading with citrate and butyrate. While we cannot accept Takeda's implication that a-a'-dipyridyl-poisoned animals are iron-deficient in a sense in any way comparable to iron deficiency produced by bleeding or by a low iron diet, it seemed worthwhile to explore aconitase activity and the metabolism of exogenously administered citrate in truly iron-deficient animals and humans.
MATERIALS AND METHODS
Unless otherwise indicated, female Holtzman strain rats have been used throughout these experiments. All animals were fed the iron-poor diet that we have described previously (7) , and were given water rendered iron free by passing it over an ion exchange resin. Unless otherwise indicated, each control rat was given 25 mg. of iron, as iron-dextran (Imferon®),' intramuscularly into the hamstring muscles in two divided doses, one at the beginning of the experiment, the other, two weeks later. The animals were not fasted prior to sacrifice. Each animal was exsanguinated from the heart under ether anesthesia. All of the organs that were removed were placed into chilled vessels.
The method of aconitase assay was based on that described by Anfinsen (15 (as anhydride) per ml. Fifteen minutes after addition of substrate, the reaction was stopped. In the case of heart, kidney and liver, this was done by adding 1 ml. of the reaction mixture to 0.5 ml. of 50 per cent (V/V) sulfuric acid in a tube marked at the 10 ml. mark. The total volume was then brought to approximately 5 ml. with distilled water. In the case of brain homogenate, the reaction was stopped by adding 5 ml. of 20 per cent trichloracetic acid to the entire 5 ml. reaction mixture; citric acid determinations were done on 5 ml. of the filtrate. Citric acid determinations were carried out according to our modification of the pentabromacetone method (16) . In this assay system, the quantity of citric acid produced is approximately linear with respect to time of reaction and to volume of tissue extract added ( Figure  1 ). One unit of enzyme activity has been defined arbitrarily as that amount of enzyme that will, in the assay system described, convert 10' Moles of cis-aconitic acid to citric acid per minute.2 Because of the slight de-parture from linearity that was sometimes observed when the amount of citric acid formed was compared with the amount of tissue extract added (Figure 1 ), two dilutions of tissue-were assayed. These dilutions were chosen so that one sample usually contained less than one unit and the other contained more than one unit of enzyme activity. The average of these two determinations has been reported. One-tenth and 0.2 ml. of the following tissue dilutions were found to be appropriate: kidney, 1 to 25 or 1 to 40; heart, 1 to 50; brain, 1 to 20; liver, 1 to 20.
The method used for assaying the aconitase activity of human white cells has been described in detail elsewhere (17) .
EXPERIMENTAL AND RESULTS

A. The reactivation of aconitase by iron
A one to 800 homogenate was prepared from the kidney of a normal rat in 0.2 M phosphate buffer, pH 7.4 The aconitase activity of the homogenate was assayed immediately and at intervals after incubation at 370 C. Solutions containing 0.03 M ferrous sulfate, 0.03 M ascorbic acid, and both were prepared and their pH adjusted to 7.4. After one hour, one volume of one of each of these solutions was added to each of three nine-volume aliquots of the incubating mixture. As a control, one volume of buffer was added to a fourth aliquot. Aconitase activity was determined at intervals. The results of this experiment, showing the time course of partial reactivation of aconitase by iron and ascorbate, are shown in Figure 2 . No reactivation was achieved by the addition of either iron or ascorbate alone.
The effect of different concentrations of iron and ascorbic acid has been investigated in a similar fashion. In three experiments, one to 800 kidney homogenate, 75 to 80 per cent inactivated by incubating for one hour at 370 C., was reactivated for 10 minutes with iron and ascorbate. Aconitate was then added and enzyme activity measured in the usual manner. It is apparent that complete reactivation of incubated enzyme could be achieved regularly when sufficiently high concentrations of iron and ascorbic acid were used.
The results of these studies are given in Figure 3 .
B. Aconitase activity of organs of-normal and iron-deficient rats and aconitase activity of kidneys, hearts and livers were determined. Eighteen 23-day-old rats were given an iron-poor diet, nine of these being injected with iron-dextran. After 10 days, four iron-deficient and four iron-treated (control) rats were sacrificed, and after 26 days, the remaining five iron-deficient and five iron-treated (control) animals were sacrified. The hemoglobin, hematocrit and plasma iron values and organ aconitase assays of these animals are presented in Table I . A well-marked decrease in aconitase activity of the kidneys of the iron-deficient animals, compared with that of the control animals, was found. In sharp contrast, the aconitase activity of the other organs studied was normal, with the possible exception of a slight reduction of heart enzymatic activity. The enzymatic activity of mixtures of equal volumes of homogenates from iron-deficient and normal animals was the arithmetic mean of the two: no inhibition of normal kidney enzyme or activation of iron-deficient kidney enzyme could be demonstrated. Rats that had always been fed stock diet had kidney aconitase activity comparable with that of the irondextran controls. Administration of iron-dextran to such rats did not cause an elevation of kidney aconitase activity. (Figure 5 ).
E. The effect of anemia on aconitase activity of non-iron-deficient animals Holtzman strain, retired male breeder rats, weighing 450 to 510 Gm., were placed on the iron-poor diet and were divided into four groups. A control group of four rats received no treatment. Another group of four animals was injected subcutaneously with 10 or 20 mg. of phenylhydrazine at two to four day intervals ( Figure 6 ). The other two groups of six rats each were bled 5 ml. from the heart three times weekly for a total of six bleedings. Six of these animals were intramuscularly injected weekly with 12.5 mg. of iron as iron-dextran. Only six bled animals, three iron-treated and three untreated, survived. The average hemoglobin levels and treatment schedules of the entire surviving experimental group are presented in Figure 6 . At the end of the 27 days, all animals were sacrificed and the hemoglobin, plasma iron and kidney aconitase activity were measured. The results, presented in Figure 7 , demonstrate that irondeficient rats (bled, but not treated with iron) had diminished kidney aconitase activity, even after relatively short-term iron deprivation. Anemia, induced by phenylhydrazine injections or by bleeding when iron supplements were given, failed to affect kidney aconitase activity. levels in plasma and urine were measured before ingestion of the loading dose and at subsequent intervals. A light breakfast consisting of a roll and coffee was given one hour after administration of citrate. The results of studies carried out in three normal and six iron-deficient subjects are shown in Figure 8 . Pertinent clinical and hematologic data are presented in Table II . The slightly higher plasma average levels and lower cumulative urinary citrate excretion of the iron-deficient subjects are deemed to be of little importance. In one mildly iron-deficient subject with high urinary citrate excretion, repeated measurements were made of six hour urinary citrate excretion following standard loading, both before and after iron therapy. No change in citrate excretion could be demonstrated (Figure 9) .
A decrease in aconitase activity has been demonstrated in the kidneys of iron-deficient rats. Weanling rats deprived of iron failed to develop the rapid increase in kidney aconitase activity that occurs when iron is administered to young rats. The activity of this enzyme decreased in mature animals rendered iron-deficient by repeated bleeding while on an iron-poor diet. It is of particular interest that the decrease in enzymatic activity in kidneys from iron-deficient Table II. rats did not appear to be due merely to a lack of iron acting as a cofactor for aconitase activity, since addition of iron failed to "reactivate" aconitase from iron-deficient animals. Normal kidney tissue also failed to reactivate enzyme from iron-deficient kidneys, and it may therefore be presumed that the decrease of aconitase activity was due to actual depletion of the protein moiety of the enzyme. In this respect, aconitase may be regarded to be similar to apoferritin, which is synthesized in response to iron (18) Measurements of citrate excretion were made following oral citrate loading on repeated occasions, before and after intravenous administration of iron in the form of saccharated iron oxide.
globin moiety of hemoglobin, synthesis of which appears to be inhibited in iron deficiency (19) . Takeda and Hara (14) have reported that poisoning with a-a'-dipyridyl results in greatly. increased urinary excretion of citric acid by guinea pigs, especially after they had been fed large quantities of citrate and butyrate. Using rats as the test animal, we have been unable to duplicate these results, using our modification of the pentabroacetone method for citrate analysis (16) . The less specific sodium sulfide (20) method used by Takeda and Hara gives a false positive reaction forcitricacid with a-a'-dipyridyl (21) . It is possible that Takeda and Hara measured a-a'-dipyridyl, or a metabolic product as citric acid. However, even true citric aciduria, if it occurs under these experimental conditions, does not necessarily indicate profound changes in intracellular citric acid metabolism: citric acid excretion is extremely sensitive to urine pH changes (22) .
In spite of our failure to confirm the results of Takeda and Hara in rats, we studied citric acid excretion in iron-deficient and normal subjects following loading with citric acid, hoping that a clinically useful means for diagnosis of iron deficiency might emerge. However, no significant difference was observed either in blood or urine citrate levels of iron-deficient and normal subjects. Obviously, this does not prove that the operation of the citric acid cycle is normal in iron-deficient subjects: the metabolism of an exogenously administered dose of citrate may be quite different from that of citrate produced within the cell by condensation of acetate and oxalacetic acid.
SUM MARY
1. The observation of Dickman and Cloutier (5, 13) , that inactivated solutions of aconitase may be reactivated by iron and a reducing agent, has been confirmed.
2. The aconitase activity of kidneys from irondeficient rats was found to be reduced consistently, but the aconitase activity of the hearts, livers and brains of iron-deficient rats was normal.
3. Aconitase from the kidneys of iron-deficient rats could not be "reactivated" by the addition of iron and ascorbate, homogenate of normal rat kidney, or heat-inactivated normal rat kidney homogenate. This finding is interpreted as indicating an actual depletion of the protein moiety of aconitase in iron-deficient animals.
4. Treatment of iron-deficient rats with iron restored their kidney aconitase activity to normal.
5. Anemia, induced by the administration of phenylhydrazine or by repeated bleeding of rats given supplemental iron, failed to reduce kidney aconitase activity; blood loss anemia in rats not given iron supplement resulted in a decrease in kidney aconitase activity.
6. Aconitase activity of human white blood cells from iron-deficient subjects was found to be normal.
7. Plasma citrate levels and urinary citrate excretion after oral loading with citrate has been studied. No difference could be demonstrated between normal and iron-deficient subjects.
